Schweer-Collins, Maria L. http://orcid.org/0000-0001-8285-9107
Parr, Nicholas J.
Saitz, Richard
Tanner-Smith, Emily E.
Funding for this research was provided by:
National Institute on Drug Abuse (R01DA043589)
Article History
Accepted: 7 March 2023
First Online: 3 May 2023
Declarations
:
: The University of Oregon Institutional Review Board (IRB) review the protocol for this review and determined that the study activities did not meet the definition of research with human subjects according to Titel 45 CFR 46.102 (d-f) and thus did not require IRB approval.
: Primary study investigators have record of informed consent; all included primary studies had informed consent procedures that allowed for sharing of de-identified data.
: ETS, NP, and MSC have no conflicts of interest to declare. RS reports personal fees from University of Oregon to support this work. RS also reports non-financial support from Alkermes, personal fees from American Society of Addiction Medicine, American Medical Association, National Council on Behavioral Healthcare, Kaiser Permanente, UpToDate/Wolters Kluwer, Yale University, National Committee on Quality Assurance, Oregon Health Sciences University, RAND Corporation, Leed Management Consulting/Harvard Medical School, Partners, Beth Israel/Deaconess Hospital, American Academy of Addiction Psychiatry, Group Health Cooperative, Checkup and Choices, International Network on Brief Interventions for Alcohol and Other Drugs (INEBRIA) supported via funds from Systembolaget, Smart Recovery, Karolinska Institute, Institute for Research and Training in the Addictions, Medical Malpractice Expert Witness, Charles University, Brandeis University, and Massachusetts Medical Society outside the submitted work; he also reports research consulting to ABT Corporation (not remunerated). RS is an author of primary studies included in this review but was not involved in the data extraction or data analysis of those studies for this review.